Company intelligence / Profile preview

1010VC

Palo Alto, California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

1010VC is an early-stage venture capital fund focused on investing in founders building breakthrough technologies at the intersection of deep science and technology. The firm specializes in bioconvergence—supporting multidisciplinary research that advances healthcare and medicine through synthetic biology, next-generation chemistry, scalable biomanufacturing, and AI/ML for life sciences. It operates globally with a strong presence in Palo Alto/Silicon Valley.

Modalities: Synthetic biologyBiomanufacturing technologiesAI/ML for life sciences
Industry: Investors

Partnerships

Works alongside accelerators, incubators, micro VCsleverages strategic networks including industry leaders from biotech/synthetic bio/healthcare sectors

Beyond the preview

Go deeper on 1010VC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1010VC.

Explore the full profile